PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Chlorprothixene→

Chlorprothixene PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
113-59-7
Molecular formula
C18H18ClNS
Molecular weight
315.86 g/mol
Drug class
Thioxanthene antipsychoticdopamine D2 receptor antagonist
Mechanism of action
Antagonises dopamine D2 receptors in central dopaminergic pathways, reducing psychotic symptoms. It also has histamine H1, alpha-adrenergic and muscarinic receptor antagonism that contributes to sedative and autonomic effects.
Indications / reported uses
  • Treatment of schizophrenia and other psychotic disorders in countries where chlorprothixene remains authorised; use and availability are jurisdiction-specific

Sources: NLM MeSH — Chlorprothixene · PubMed — Chlorprothixene antipsychotic pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Chlorprothixene PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Chlorprothixene Permitted Daily Exposure (PDE) report (the Chlorprothixene PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Chlorprothixene Occupational Exposure Limit (OEL) report (the Chlorprothixene OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.